Hansoh Pharmaceutical's Ameile Wins New NMPA Approval for Advanced NSCLC Treatment
CompanyDigital

Hansoh Pharmaceutical’s Ameile Wins New NMPA Approval for Advanced NSCLC Treatment

IMEIK REGEN Biotech Acquisition Medical Aesthetics Products
CompanyDeals

IMEIK Technology Development Co.,Ltd Acquires Majority Stake in REGEN Biotech via Joint Venture

Lundbeck's Amlenetug Receives Orphan Drug Designation in Japan for Multiple System Atrophy
CompanyDrug

Lundbeck’s Amlenetug Receives Orphan Drug Designation in Japan for Multiple System Atrophy

Shenzhen GeneMind Biosciences Partners with Precisiongenes for Molecular Diagnostic Innovation
CompanyDeals

Shenzhen GeneMind Biosciences Partners with Precisiongenes for Molecular Diagnostic Innovation

Juvensis Therapeutics Heart Gene Therapy Anti-Aging
CompanyDeals

Juvensis Therapeutics Secures RMB100 Million for Heart Gene Therapy Development

Jiangsu Hengrui Pharmaceuticals Receives NMPA Approval for HRS-4029 in Acute Ischemic Stroke
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Receives NMPA Approval for HRS-4029 in Acute Ischemic Stroke

InnoCare Pharma Presents Positive Phase II Results of ICP-488 in Psoriasis at AAD Meeting
CompanyDrug

InnoCare Pharma Presents Positive Phase II Results of ICP-488 in Psoriasis at AAD Meeting

Nona Biosciences Launches Hu-mAtrIx: AI-Driven Engine for Accelerated Antibody Drug Discovery
Company

Nona Biosciences Launches Hu-mAtrIx: AI-Driven Engine for Accelerated Antibody Drug Discovery

Sichuan Biokin Pharmaceutical Plans RMB3.9 Billion Private Placement for Novel Drug R&D
CompanyDeals

Sichuan Biokin Pharmaceutical Plans RMB3.9 Billion Private Placement for Novel Drug R&D

LiteDD's LIT0922 Approved for Phase I Trial in Marker-Expressing Advanced Solid Tumors
CompanyDrug

LiteDD’s LIT0922 Approved for Phase I Trial in Marker-Expressing Advanced Solid Tumors

Jiangsu Hengrui Pharmaceuticals Receives NMPA Approval for SHR-4602 Clinical Study in Advanced Solid Tumors
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Receives NMPA Approval for SHR-4602 Clinical Study in Advanced Solid Tumors

Jiangsu Cowin Biotech Obtains NMPA License for Gene Methylation Detection Kit
CompanyMedical Device

Jiangsu Cowin Biotech Obtains NMPA License for Gene Methylation Detection Kit